When a sibling was diagnosed with irritable bowel syndrome, Doctor Onikepe Adegbola was surprised by how difficult it was to eat following an IBS diet. That is why the doctor has launched Casa de Sante, a "FODMAP" approved food brand.
Casa de Sante produces full food like salsa as well as ingredients that are low in FODMAPs. FODMAP are fermentable carbohydrates found naturally in a variety of fruits, vegetables, grains, legumes and milk products. These carbohydrates are not digested and are then fermented by the bacteria in the stomach. This creates gas and bubbles that result in bloating and cramping. Low FODMAP diets are designed to limit foods that contain these carbohydrates.
Dr. Adegbola says the response to her brand has been strong. She is happy to be providing options that are making the lives of the tens of millions of people suffering with IBS in the United States easier.
Blame geography for the U.S. getting hit by stronger, costlier, more varied and frequent extreme weather than anywhere on the planet, several experts said. But that's only part of it.
Residents across a wide swath of the U.S. raced Sunday to assess the destruction from fierce storms that spawned possibly dozens of tornadoes from the South and the Midwest into the Northeast.
The U.S. Food and Drug Administration has approved selling overdose antidote naloxone over-the-counter, marking the first time a opioid treatment drug will be available without a prescription.
Millions of Americans could lose access to Medicaid on April 1, and Joe Dunn, senior vice president of public policy at the National Association of Community Health Centers, joined Cheddar News' anchor Shannon LaNier to discuss what this means for public health.
One third of Americans don't have access to primary care providers in their communities, according to a study from the National Association of Community Health Centers published last month.
Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report.